Microdacyn for wound cleansing
Severe leg ulcers, pressure ulcers and diabetic foot cause great suffering for the affected and is associated with a large cost for the healthcare system. These wounds are difficult to treat and there is no consensus on best treatment. Microdacyn, formerly Dermacyn, is marketed as "an effective agent for the care and healing of chronic wounds, diabetic foot, burns, eye infection, viruses and fungi." and is approved as a Class IIB medical device product.